A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: https://films.economist.com/nowandnext/<br /><br />Further content:<br /><br />Find The Economist’s most recent coverage of covid-19 here: https://econ.st/3iwmMMH <br /><br />Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis: https://econ.st/2Ckne0X <br /><br />The immense promise of the new covid-19 vaccine, and the challenges still to come: https://econ.st/36EgZAd <br /><br />Why an effective covid-19 vaccine is a turning point in the pandemic: https://econ.st/3kJfJRr<br /><br />Read more about Pfizer’s and BioNTech’s vaccine: https://econ.st/3pyBvem <br /><br />A second, better, vaccine against covid-19 arrives—read about Moderna’s vaccine: https://econ.st/3kEfOpE <br /><br />Rich countries have grabbed half of projected covid-19 vaccine supply: https://econ.st/3nveNSm <br /><br />Daily chart: One in three people want preferential access to a covid-19 vaccine: https://econ.st/2IyoYah <br /><br />How pandemic fears are boosting demand for trustworthy news: https://econ.st/2UzCMU7 <br /><br />Super fast tests for covid-19 are coming: https://econ.st/32S1Ie5 <br /><br />How the quest for a vaccine could restore faith in big pharma: https://econ.st/32RSRJn
